. . . . . . . "[Using both in vitro and in vivo studies, we observed that EETs significantly attenuated bone loss and inhibited osteoclast formation and activity, which were associated with a decreased receptor activator of NF-?B ligand (RANKL):osteoprotegerin ratio and serum levels of TNF-? and IL-1?.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en . . . . . "2017-02-19"^^ . . "Gene-disease associations inferred from text-mining the literature."@en . "DisGeNET evidence - LITERATURE"@en . "2017-10-17T13:16:47+02:00"^^ . . . . . . . . . . . "v5.0.0.0" . "v5.0.0" .